Navamedic ASA at its annual general meeting held on June 1, 2023, elected Åsa Kornfeld as members of the Company's board of directors for a one-year term, until the annual general meeting in 2024. Åsa Kornfeld served as a Board member of Sensidose AB when Navamedic ASA acquired the company. She is Pricing & Access Lead in Recordati Rare Diseases based in Paris, and has extensive experience from the pharmaceutical industry, with more than 25 years of international experience.

She holds an M.Sc Medicinces and Healthcare products from Université de Bordeaux, and Finance for Executives from INSEAD.